Page last updated: 2024-08-25

amperozide and Basal Ganglia Diseases

amperozide has been researched along with Basal Ganglia Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breier, A	1
Axelsson, R; Björk, A; Christensson, E; Nilsson, A	1

Reviews

1 review(s) available for amperozide and Basal Ganglia Diseases

Article	Year
Serotonin, schizophrenia and antipsychotic drug action. Schizophrenia research, 1995, Volume: 14, Issue:3 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Humans; Isoxazoles; Piperazines; Piperidines; Risperidone; Schizophrenia; Serotonin; Tryptophan	1995

Other Studies

1 other study(ies) available for amperozide and Basal Ganglia Diseases

Article	Year
Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist. Psychopharmacology, 1991, Volume: 104, Issue:3 Topics: Adult; Basal Ganglia Diseases; Body Temperature; Body Weight; Dose-Response Relationship, Drug; Electrocardiography; Hemodynamics; Humans; Male; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists	1991

Article

Year

Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.

Psychopharmacology, 1991, Volume: 104, Issue:3

Topics: Adult; Basal Ganglia Diseases; Body Temperature; Body Weight; Dose-Response Relationship, Drug; Electrocardiography; Hemodynamics; Humans; Male; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists

1991